(Q51788283)

English

No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer.

scientific article published on 29 November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

author name string

Frederik Anton Verburg

1

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

Marcel P M Stokkel

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

Christian Düren

3

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

Robbert B T Verkooijen

4

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

Uwe Mäder

5

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

Johannes W van Isselt

6

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

Robert J Marlowe

7

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

Johannes W Smit

8

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

Christoph Reiners

9

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

Markus Luster

10

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

publication date

29 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

37

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

276-283

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

https://scigraph.springernature.com/pub.10.1007/s00259-009-1315-6

0 references

Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical management of thyroid cancer: a risk adapted approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fixed dosage of 131I for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigraphy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20091165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-009-1315-6

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/20091165

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51788283&oldid=1404952637"